TOI ONCOLOGY INSTITUTE INC (THE)

WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio

WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio

CERRITOS, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- WellBe Senior Medical announced today that it is strengthening its cancer care capabilities to further support its mission of managing the population health of polychronic Medicare Advantage patients by partnering with leading cancer care provider, The Oncology Institute, Inc. (NASDAQ: TOI).

WellBe now offers The Oncology Institute’s High-Value Cancer Care Program to eligible patients in Illinois and Ohio. As part of this program, TOI provides care management and supportive care services customized to the needs of the individual patient with active cancer diagnoses. This program has demonstrated significant improvements in patient satisfaction, less acute care facility utilization, and is focused on addressing the supportive care needs of patients without displacing the community oncologist.

“At WellBe, we partner with health plans to care for their most complex members and bring customized care to their homes,” shared Dr. Iyad Houshan, Chief Medical Officer of WellBe Senior Medical. “A cancer diagnosis is a life-changing event for all, and especially for seniors with multiple chronic conditions. We chose The Oncology Institute to partner with so that we can offer added care and resources to our patients and their families to help mitigate some of the burdens during a cancer treatment episode.”

“We are excited about the opportunity to serve more patients in partnership with WellBe Senior Medical across these two new states for TOI,” commented Dr. Daniel Virnich, CEO of The Oncology Institute. “WellBe’s mission to provide tailored care to the frailest seniors aligns with TOI’s goals in cancer care. We have been refining this program for many years and have published outcomes that show benefit for patients. Our model ensures that we are providing complementary services to manage patient experience and acute care utilization in addition to the services that a community-based oncologist can provide.”

About The Oncology Institute

Founded in 2007, The Oncology Institute, Inc. (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit .

About WellBe Senior Care

WellBe Senior Medical works with health insurance plans to provide home-based medical care to patients who are facing multiple complex health challenges. WellBe’s healthcare experts are committed to providing personalized appointments wherever our patients call home. Our care team works together with patients, their caregivers, and physicians to nurture all aspects of health. For more information, please visit or call 1-855-477-4151.

Contacts

Investors

Solebury Strategic Communications



EN
25/01/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONCOLOGY INSTITUTE INC (THE)

 PRESS RELEASE

The Oncology Institute to Participate in Panel Discussion at the Leeri...

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024. About The Oncology Institute, Inc. Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI)...

 PRESS RELEASE

The Oncology Institute Announces First Quarter 2024 Earnings Release D...

The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call CERRITOS, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2024 financial results after the market close on Tuesday, May 14, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-...

 PRESS RELEASE

Jordan McInerney Appointed as Chief Development Officer of The Oncolog...

Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute Executive Brings Wealth of Experience in Advancing Value-Based Specialty Care Models CERRITOS, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is pleased to announce the appointment of Jordan McInerney as the new Chief Development Officer (CDO), effective April 1, 2024. In this role, Mr. McInerney will spearhead growth initiatives for The Oncology Institute across diverse markets, including cultivating new partnerships with payors, driving M&A pr...

 PRESS RELEASE

The Oncology Institute and Healthly Forge Strategic Alliance to Elevat...

The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California CERRITOS, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) and Healthly, a rapidly growing healthcare company with over 180 primary care physicians, support services, and a focus on preventive medicine, have announced a strategic collaboration aimed at extending high-quality cancer care services to patients throughout Southern California. Commencing July 1, 2024, TOI will offer its cancer care ser...

 PRESS RELEASE

The Oncology Institute Reports Fourth Quarter and Full Year 2023 Finan...

The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024 CERRITOS, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2023. Recent Operational Highlights Remediated material weakness in Internal Controls over review of Complex Accounting Transactions.Signed full-risk capitated contract in South Florida, effective Januar...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch